Towards molecular imaging-guided intervention theatres in oncology.

The article discusses the role of molecular imaging in oncology and its potential to guide interventional procedures. Molecular imaging, particularly positron emission tomography (PET), has become essential in clinical practice for diagnosing, staging, and monitoring treatment responses in cancer patients. The article explores how novel molecular imaging modalities, such as optical imaging and photoacoustic imaging, offer high precision and real-time feedback for guiding interventions like biopsies, surgeries, and ablations. The integration of molecular imaging into these procedures can improve accuracy, efficiency, and patient outcomes. The article emphasizes the need for multidisciplinary collaboration and further research to fully realize the potential of molecular imaging in clinical practice. [Extracted from the article]